Welcome to the 4th ADC Analytical Development Summit
Ensure Regulatory Compliance Through a High-Quality ADC Product
The ADC landscape is becoming increasingly competitive, and considering the FDA’s updated ICH Q14 guidance, the focal point of anyone working in ADC analytical development is how to ensure ADC product quality in keeping with stricter specifications. At this pivotal moment, the 4th ADC Analytical Development Summit returns to the World ADC Event Series, bringing together experts to address the unique analytical challenges of antibody-drug conjugates to help you navigate an increasingly crowded industry.
Raising the bar for release and stability testing and adopting advanced analytical methods is crucial to maintaining product quality ascertaining to updated FDA guidance. Liaising with your peers will offer you a platform to explore how to meet regulatory requirements effectively while ensuring your ADC remains robust through its lifecycle, with case studies from experts in regulatory submissions.
Take this chance to discover how cutting-edge analytical tools are revolutionizing bioassays, enhancing potency measurement, and unlocking deeper insights into ADC mechanisms of action. Gain powerful, actionable strategies to refine impurity assays, precisely quantify free drug and process-related impurities, and ensure your ADCs meet the highest global regulatory standards with confidence.
Our World-Class Speaker Faculty Includes:
*Large Pharma Attending This Year!
Our Partners:
“It was a great time for pioneers in the ADC field to share their valuable experiences generously and meet people who sympathize with the analytical problems I face.” Manager, Kanaph Therapeutics